LifeVantage CorporationLFVNNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank50
3Y CAGR+37.2%
5Y CAGR-3.1%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+37.2%/yr
vs -11.3%/yr prior
5Y CAGR
-3.1%/yr
Recent acceleration
Acceleration
+48.5pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.70+79.1%
20240.39+52.9%
20230.26-5.8%
20220.27-42.2%
20210.47-42.6%
20200.82-1.5%
20190.83+89.5%
20180.44+45.6%
20170.30-66.7%
20160.90-